A pediatric case of lymphomatoid granulomatosis with onset after completion of chemotherapy for acute myeloid leukemia

J Pediatr Hematol Oncol. 2003 Feb;25(2):163-6. doi: 10.1097/00043426-200302000-00016.

Abstract

In this case report, we present a pediatric case of lymphomatoid granulomatosis (LG) with onset just after the completion of chemotherapy for childhood acute myeloid leukemia (AML). After the completion of maintenance therapy, the patient was admitted to our clinic with a complaint of cough. Radiologic examinations revealed nodular lesions in lungs, liver, and kidney. His bone marrow was in remission. The histopathologic examination of the open lung biopsy was consistent with LG. He received only one cycle of cyclophosphamide and high-dose methyl prednisolone treatment and continued to receive interferon (IFN) alpha-2b therapy for 18 months. This treatment regimen resulted in an excellent response. In conclusion, LG may occur after the treatment of pediatric AML as a rare complication and IFN alpha-2b may be an effective treatment choice in these patients.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Cyclophosphamide / administration & dosage
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Kidney Neoplasms / diagnosis*
  • Kidney Neoplasms / drug therapy
  • Leukemia, Myeloid / drug therapy*
  • Liver Neoplasms / diagnosis*
  • Liver Neoplasms / drug therapy
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / drug therapy
  • Lymphomatoid Granulomatosis / diagnosis*
  • Lymphomatoid Granulomatosis / drug therapy
  • Male
  • Methylprednisolone / administration & dosage
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Cyclophosphamide
  • Methylprednisolone